pemetrexed 100mg powder for concentrate for solution for infusion vials
seacross pharmaceuticals ltd - pemetrexed disodium - powder for solution for infusion - 100mg
pemetrexed 500mg powder for concentrate for solution for infusion vials
seacross pharmaceuticals ltd - pemetrexed disodium - powder for solution for infusion - 500mg
pemetrexed seacross 100 mg powder for concentrate for solution for infusion
seacross pharma (europe) limited - pemetrexed - powder for concentrate for solution for infusion - 100 milligram(s) - folic acid analogues; pemetrexed
pemetrexed seacross 500 mg powder for concentrate for solution for infusion
seacross pharma (europe) limited - pemetrexed - powder for concentrate for solution for infusion - 500 milligram(s) - folic acid analogues; pemetrexed
docetaxel 20mg/ml concentrate for solution for infusion
seacross pharmaceuticals limited - docetaxel anhydrous - concentrate for solution for infusion - 20 milligram(s)/millilitre - taxanes; docetaxel
epirubicin
seacross pharmaceuticals limited - epirubicin hydrochloride - solution for injection - 2 mg/ml - epirubicin
docetaxel 80 10 milligram concentrate for soln for inf
seacross pharmaceuticals - docetaxel anhydrous - concentrate for soln for inf - 80 10 milligram
palonosetron seacross
a.l. medi-market ltd. - palonosetron as hydrochloride - solution for injection - palonosetron as hydrochloride 50 mcg / 1 ml - palonosetron - palonosetron seacross is indicated in adults and in paediatric patients 1 month of age and older for the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy, and prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.
azacitidine seacross 25 mg/ml powder for suspension for injection
seacross pharma (europe) limited - azacitidine - powder for suspension for injection - 25 milligram(s)/millilitre - azacitidine
plerixafor seacross 20 mg/ml solution for injection
seacross pharma (europe) limited - plerixafor - solution for injection - plerixafor